ACADIA Pharmaceuticals, Inc. (ACAD)
28.91
-0.20
(-0.69%)
USD |
NASDAQ |
Aug 31, 16:00
28.91
0.00 (0.00%)
After-Hours: 20:00
ACADIA Pharmaceuticals Cash from Operations (TTM) : 160.32M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 160.32M |
| March 31, 2026 | 123.49M |
| December 31, 2025 | 109.84M |
| September 30, 2025 | 198.95M |
| June 30, 2025 | 187.91M |
| March 31, 2025 | 148.96M |
| December 31, 2024 | 157.72M |
| September 30, 2024 | 202.73M |
| June 30, 2024 | 80.53M |
| March 31, 2024 | 63.71M |
| December 31, 2023 | 16.70M |
| September 30, 2023 | -92.54M |
| June 30, 2023 | -34.31M |
| March 31, 2023 | -55.64M |
| December 31, 2022 | -114.04M |
| September 30, 2022 | -113.30M |
| June 30, 2022 | -129.64M |
| March 31, 2022 | -141.84M |
| December 31, 2021 | -125.66M |
| September 30, 2021 | -130.03M |
| June 30, 2021 | -135.76M |
| March 31, 2021 | -147.31M |
| December 31, 2020 | -136.17M |
| September 30, 2020 | -138.38M |
| June 30, 2020 | -134.44M |
| Date | Value |
|---|---|
| March 31, 2020 | -135.96M |
| December 31, 2019 | -151.13M |
| September 30, 2019 | -160.50M |
| June 30, 2019 | -183.93M |
| March 31, 2019 | -186.41M |
| December 31, 2018 | -167.47M |
| September 30, 2018 | -158.29M |
| June 30, 2018 | -174.41M |
| March 31, 2018 | -192.43M |
| December 31, 2017 | -217.76M |
| September 30, 2017 | -251.05M |
| June 30, 2017 | -241.91M |
| March 31, 2017 | -237.76M |
| December 31, 2016 | -208.41M |
| September 30, 2016 | -179.57M |
| June 30, 2016 | -162.16M |
| March 31, 2016 | -137.29M |
| December 31, 2015 | -121.42M |
| September 30, 2015 | -104.87M |
| June 30, 2015 | -90.50M |
| March 31, 2015 | -77.60M |
| December 31, 2014 | -66.43M |
| September 30, 2014 | -58.90M |
| June 30, 2014 | -50.89M |
| March 31, 2014 | -39.37M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Incyte Corp. | 1.980B |
| Agios Pharmaceuticals, Inc. | -360.60M |
| Biogen, Inc. | 2.879B |
| Insmed, Inc. | -778.92M |
| Vertex Pharmaceuticals, Inc. | 4.293B |